 
<prompt> Trends in Intermittent Preventive Treatment during Pregnancy (IPTp) | Percent of women age 15-49 with a live birth in past 2 years who received at least 1, 2, or 3 doses of SP/Fansidar | (1+ dose, EDSM 2006, 16) (2+ doses, EDSM 2006, 11) (3+ doses, EDSM 2006, 6) (1+ dose, EDSM 2012-13, 56) (2+ doses, EDSM 2012-13, 30) (3+ doses, EDSM 2012-13, 12) (1+ dose, EDSM 2015, 66) (2+ doses, EDSM 2015, 44) (3+ doses, EDSM 2015, 21) (1+ dose, EDSM 2018, 74) (2+ doses, EDSM 2018, 55) (3+ doses, EDSM 2018, 28) <response> Nearly 3 in 4 (74%) pregnant women receive one dose of SP/Fansidar, 55% receive two doses, and 28% receive 3+ doses of SP/ Fansidar. The percent of women receiving SP/Fansidar has increased since 2006 when only 16% of women received at least one dose of SP/Fansidar.  